Clarithromycin regresses endometriotic implants in rat endometriosis model

References

• Abdallah MA, Kang S, Nakajima ST, Gercel-Taylor C. 2006. Matrix metalloproteinase-9 activity in the plasma of patients after surgical resection of endometriomas. Fertility and Sterility 85:1847–1848.
   PubMed Web of Science ®Google Scholar
• Akkaya P, Onalan G, Haberal N, Bayraktar N, Mülayim B, Zeyneloglu HB. 2009. Doxycycline causes regression of endometriotic implants: a rat model. Human Reproduction24:1900–1908.
   Google Scholar
• Cheung C, Marchant D, Walker EK, Luo Z, Zhang J, Yanagawa B, et al. 2008. Ablation of matrix metalloproteinase-9increases severity of viral myocarditis in mice. Circulation 117:1574–1582.
   PubMed Web of Science ®Google Scholar
• Collette T, Maheux R, Mailloux J, Akoum A. 2006. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Human Reproduction 21:3059–3067.
   PubMed Web of Science ®Google Scholar
• Culić O, Eraković V, Parnham MJ. 2001. Anti-inflammatory effects of macrolide antibiotics. European Journal of Pharmacology 429:209–229.
   PubMed Web of Science ®Google Scholar
• Dogan E, Saygili U, Posaci C, Tuna B, Caliskan S, Altunyurt S, et al. 2004. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertility and Sterility 82: 1115–1120.
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ. 2008. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. International Journal of Antimicrobial Agents 31:12–20.
   PubMed Web of Science ®Google Scholar
• Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. 1984. Retrograde menstruation in healthy women and in patients with endometriosis. Obstetrics and Gynecology 64:151–154.
   PubMed Web of Science ®Google Scholar
• Hishikari K, Watanabe R, Ogawa M, Suzuki J, Masumura M, Shimizu T, et al. 2010. Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity. Heart 96:523–527.
   PubMed Web of Science ®Google Scholar
• Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudle MR, Bukovsky A. 1999. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertility and Sterility 72:135–141.
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Kir M, Casey CL. 2004. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertility and Sterility 82:1008–1113.
   PubMed Web of Science ®Google Scholar
• Macer ML, Taylor HS. 2012.Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstetrics and Gynecology Clinics of North America 39:535–549.
   Google Scholar
• Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. 2000. Matrix metalloproteinases: biologic activity and clinical implications. Journal of Clinical Oncology 18:1135–1149.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Suzuki J, Hishikari K, Takayama K, Tanaka H, Isobe M. 2008. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. Journal of the American College of Cardiology 51:1977–1985.
   PubMed Web of Science ®Google Scholar
• Olive DL, Pritts EA. 2001. Treatment of endometriosis. The New England Journal of Medicine 345:266–275.
   PubMed Web of Science ®Google Scholar
• Pan H, Sheng JZ, Tang L, Zhu R, Zhou TH, Huang HF. 2008.Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients. Fertility and Sterility 90:1000–1007.
   Google Scholar
• Sampson JA.1927.Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. American Journal of Pathology 3:93–110.
   Google Scholar
• Sassa K, Mizushima Y, Kobayashi M. 1999. Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. Antimicrobial Agents and Chemotherapy 43:2787–2789.
   PubMed Web of Science ®Google Scholar
• Sharpe-Timms KL, Zimmer RL, Jolliff WJ, Wright JA, Nothnick WB, Curry TE. 1998. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertility and Sterility 69:916–923.
   PubMed Web of Science ®Google Scholar
• Sugamata M, Ihara T, Uchide I, Imano R, Fujiwara H, Suzuki M, et al.2004. [Effects of clarithromycin on a rat endometriosis model: light and electron microscopic evaluation]. The Japanese Journal of Antibiotics 57 Suppl A:18–20.
   PubMedGoogle Scholar
• Tkalcević VI, Bosnjak B, Pasalić I, Hrvacić B, Situm K, Kramarić MD, et al. 2008. The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice. International Journal of Antimicrobial Agents 32:195–196.
   PubMed Web of Science ®Google Scholar
• Umezawa M, Tanaka N, Takeda K, Ihara T, Sugamata M. 2011. Clarithromycin and telithromycin increases interleukin-10 expression in the rat endometriosis model. Cytokine. 55:339–342.
   PubMed Web of Science ®Google Scholar
• Vernon MW, Wilson EA.1985. Studies on the surgical induction of endometriosis in the rat. Fertility and Sterility 44:684–694.
   PubMed Web of Science ®Google Scholar